ADAGIO MEDICAL HOLDINGS INC (ADGM) Stock Price, Forecast & Analysis

NASDAQ:ADGM • US00534B1008

1 USD
-0.01 (-0.99%)
Last: Feb 12, 2026, 08:00 PM

ADGM Key Statistics, Chart & Performance

Key Statistics
Market Cap21.18M
Revenue(TTM)137.00K
Net Income(TTM)-79.15M
Shares21.18M
Float9.61M
52 Week High2.87
52 Week Low0.63
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-4.75
PEN/A
Fwd PEN/A
Earnings (Next)03-26
IPO2021-02-26
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
ADGM short term performance overview.The bars show the price performance of ADGM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20 -20

ADGM long term performance overview.The bars show the price performance of ADGM in the last 1, 2 and 3 years. 1 year 2 years 3 years -5 -10 -15 -20

The current stock price of ADGM is 1 USD. In the past month the price increased by 13.78%. In the past year, price decreased by -22.48%.

ADAGIO MEDICAL HOLDINGS INC / ADGM Daily stock chart

ADGM Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to ADGM. When comparing the yearly performance of all stocks, ADGM turns out to be only a medium performer in the overall market: it outperformed 49.05% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
ADGM Full Technical Analysis Report

ADGM Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to ADGM. ADGM may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
ADGM Full Fundamental Analysis Report

ADGM Financial Highlights

Over the last trailing twelve months ADGM reported a non-GAAP Earnings per Share(EPS) of -4.75. The EPS decreased by -229.28% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -250.89%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-105.56%
Sales Q2Q%-100%
EPS 1Y (TTM)-229.28%
Revenue 1Y (TTM)-68.79%
ADGM financials

ADGM Forecast & Estimates

7 analysts have analysed ADGM and the average price target is 4.08 USD. This implies a price increase of 308% is expected in the next year compared to the current price of 1.

For the next year, analysts expect an EPS growth of 65.5% and a revenue growth -100% for ADGM


Analysts
Analysts82.86
Price Target4.08 (308%)
EPS Next Y65.5%
Revenue Next Year-100%
ADGM Analyst EstimatesADGM Analyst Ratings

ADGM Ownership

Ownership
Inst Owners21.13%
Ins Owners3.47%
Short Float %0.6%
Short Ratio0.31
ADGM Ownership

ADGM Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABT ABBOTT LABORATORIES19.41197.518B
ISRG INTUITIVE SURGICAL INC46.82175.875B
SYK STRYKER CORP24.2139.086B
BSX BOSTON SCIENTIFIC CORP21.16108.957B
IDXX IDEXX LABORATORIES INC41.6651.801B
BDX BECTON DICKINSON AND CO11.2851.46B
EW EDWARDS LIFESCIENCES CORP25.7146.035B
RMD RESMED INC20.0137.897B
GEHC GE HEALTHCARE TECHNOLOGY15.6636.095B
DXCM DEXCOM INC25.7826.58B

About ADGM

Company Profile

ADGM logo image Adagio Medical Holdings, Inc. is a medical device company, which engages in the development ablation technologies for the treatment of cardiac arrhythmias. The company is headquartered in Laguna Hills, California and currently employs 86 full-time employees. The company went IPO on 2021-02-26. The company is focused on developing proprietary Ultra-Low Temperature Cryoablation technology that creates contiguous, transmural lesions to treat cardiac arrhythmias, with an emphasis on ventricular tachycardia. The company is developing and placing on the European Union (EU) market ablation technologies for the treatment of cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. Its product portfolio consists of three product families: iCLAS atrial ULTC catheter and accessories, vCLAS ventricular ULTC catheter, and Cryopulse atrial PFCA catheter and accessories. All of these catheters share the same ULTC cryoablation console. The iCLAS system is CE-marked with the indication for treatment of paroxysmal atrial fibrillation, persistent atrial fibrillation and atrial flutter. The vCLAS ventricular catheter has been specifically designed for the treatment of ventricular arrhythmia.

Company Info

ADAGIO MEDICAL HOLDINGS INC

26051 Merit Circle, Suite 102

Laguna Hills CALIFORNIA US

Employees: 86

ADGM Company Website

Phone: 19493481188

ADAGIO MEDICAL HOLDINGS INC / ADGM FAQ

What does ADAGIO MEDICAL HOLDINGS INC do?

Adagio Medical Holdings, Inc. is a medical device company, which engages in the development ablation technologies for the treatment of cardiac arrhythmias. The company is headquartered in Laguna Hills, California and currently employs 86 full-time employees. The company went IPO on 2021-02-26. The company is focused on developing proprietary Ultra-Low Temperature Cryoablation technology that creates contiguous, transmural lesions to treat cardiac arrhythmias, with an emphasis on ventricular tachycardia. The company is developing and placing on the European Union (EU) market ablation technologies for the treatment of cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. Its product portfolio consists of three product families: iCLAS atrial ULTC catheter and accessories, vCLAS ventricular ULTC catheter, and Cryopulse atrial PFCA catheter and accessories. All of these catheters share the same ULTC cryoablation console. The iCLAS system is CE-marked with the indication for treatment of paroxysmal atrial fibrillation, persistent atrial fibrillation and atrial flutter. The vCLAS ventricular catheter has been specifically designed for the treatment of ventricular arrhythmia.


What is the current price of ADGM stock?

The current stock price of ADGM is 1 USD. The price decreased by -0.99% in the last trading session.


Does ADGM stock pay dividends?

ADGM does not pay a dividend.


What is the ChartMill rating of ADAGIO MEDICAL HOLDINGS INC stock?

ADGM has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Can you provide the sector and industry classification for ADAGIO MEDICAL HOLDINGS INC?

ADAGIO MEDICAL HOLDINGS INC (ADGM) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


What is the Price/Earnings (PE) ratio of ADAGIO MEDICAL HOLDINGS INC (ADGM)?

ADAGIO MEDICAL HOLDINGS INC (ADGM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.75).


Would investing in ADAGIO MEDICAL HOLDINGS INC be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ADGM.